French pharmaceutical company said drug could treat COVID-19 patients after promising test results
A leading French pharmaceutical company said it could potentially treat 300,000 COVID-19 patients with the anti-malarial drug Plaquenil after what it described as “promising” test results.
Sanofi said it was ready to offer France millions of doses of Plaquenil, a spokesperson for the laboratory told AFP, adding that the group was ready to work with French health authorities “to confirm these results.”
The study on 24 patients with coronavirus using Plaquenil, a hydroxychloroquine molecule, which has also been used for decades for the treatment of autoimmune diseases like lupus or rheumatoid arthritis.
Six days after the start of taking Plaquenil, the virus had disappeared in three-quarters of those treated, said Professor Didier Raoult, who is director of the Institut Hospitalo-Universitaire de Marseille.
The French government said the clinical trials were “promising” and would be extended to more patients.
You may be interested
Visit the Greek island in the 100 most impressive list in the world (video)Panos - May 18, 2021
Ios was recently included in the list of the most impressive islands in the world on the news site Insider.com.…
The cave beach always under shade is only 1-hour away from Athens (beautiful video)Panos - May 18, 2021
Most know the famous parts of Greece and its renowned the world over beaches. But, the more one searches, the…
You can build your own Earth 2.0 with the awesome website “Earth-like”Panos - May 18, 2021
You can now build your very own Earth 2.0! A new website allows users to create an Earth-like planet with a wide…